Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Placebos usually do have an excellent safety profile.
This board thinks every document ever produced had DCVax in mind. And here it is, no FDA submission and a probable MHRA rejection in the next couple months.
The probability of the submission being accepted from a company that has problems translating documents, making copies, avoiding the flu, and hitting any deadlines is about 0.000003%.
The only way to prove a long tail is with a randomized controlled trial.
IMUC and CLDX both had “long tails”.
The 5% SOC 5 year survivors are “long tail”.
Quit listening to SOS. He’s an idiot.
The real question is why would someone want to make a biosimilar to something that doesn’t work unless they are trying to corner the expensive placebo market.
You forgot the part where the treatment group mOS dropped to 22.3 from 23.1 AFTER they removed the control patients.
So the easiest explanation is 22.3 < 23.1. At best, DCVAX doesn’t do anything.
She sold a company she built with your shares. How’s that work for you? Pretty soon you can relive it. Advent is next.
Once she saw how easy it was to sucker shareholders into financing and selling Cognate for her personal wealth, who could blame her for running it back?
He has 4 imaginary friends. Get it straight!
First it was gonna be Beau Biden getting DCVax, and then it wasn’t even though the White House is a few metro stops from NWBO HQ AND they weren’t OTC at the time. And then it wasn’t!
Then it was gonna be former board member Susan Bayh, LITERALLY ON THE BOARD OF THE COMPANY, and even she didn’t choose DCVAX.
NOW THE king of England must be secretly getting it off label!
Can’t make this shit up.
10 more years? At some point Advent is built out enough and has enough other customers that LP can sell it for a few hundred million and close up shop.
It was a great way to pump the price while dumping shares.
Yes. Believing this is a scam has nothing to do with my cancer, my mother’s cancer, or my father’s cancer.
If LP was so into helping cancer patients and DCvax really worked she would have sold the company by now. There were no takers because BP has teams of statisticians and oncologists that do nothing but look at other companies to acquire. They passed on it.
Wouldn't you want more shorting since all the shills here think there are a billion shares shorted and any day now this will be approved across the world for every cancer, off label for flatulence, and replacing Viagra and Ozempic and the shorts will burn?
"It'll happen soon." - Linda Powers, 2017.
I know how to read a PR. And how not to throw money at a shitty stock. So I'm 2 for 2 vs you.
Did you read the PR, moron?
"Several months".
Shall we recap all the times "several months" in NWBO speak ended up being years? And "soon" being NEVER.
Now we can recap how great NWBO is at picking contractors. And then blaming delays on them.
Don't you have another wall of text to write?
They haven't identified the time it takes to make an actual non-prototype cGMP Flaskworks machine either. "Several months" can easily equal 36+ months.
Gee Astrazeneca and GSK are located in the same area too. I guess all 3 are throwing trillion dollar bids on an OTC bioturd that has no products.
Your sarcastic attempt pointed out a truth. They haven't done the testing yet. Luckily the submission will be rejected so it's a moot point that they don't even have a non-prototype built, let alone tested for comparability.
Not to mention they haven't even built a non-prototype unit yet. "Several months" in NWBO speak is 5 years.
You don't think all the king's horses and all the king's men are scouring OTC stocks to find a 20 year old hidden gem like NWBO?
Or just read the latest 10Q and quit listening to people who claim to "get info from inside the building".
Congrats on being the bird gobbling up flipper's endless breadcrumbs.
Yeah because they don't pay anyone millions of dollars to do just that. Evaluate companies earning potential.
Are you really that dense? This trial has been going on over 10 years with more problems than ever. Any BP knows this and knew it 5 years ago. The trial is a trainwreck, the data is a trainwreck, and BP has plenty of money to buy cheaper trains and wreck them.
You've directed these same concerns to the paid shills, right who can't say any single negative thing about a company that's been running and changing the same trial multiple times for 10+ years? Hoffman, Blablah, flipper?
The exact same thing could be said about those who appear to be paid by the company to pump bullshit into the board. Biosectinvestor?
I don't know the dude you are referring to, but perhaps it's someone who got banned for a stupid reason and decided on another screen name to vent? Just like hoffman did with multiple aliases.
If you want to know the guy's motive, then maybe everyone should post their motive? The company pays 4 other companies to pump the stock. You don't think they pay anyone here to pump it?
If LP gave a shit about cancer patients this trial would have been finished and submitted for approval 5 years ago based on criteria of the protocol.
Instead she’s a self serving sheister building a second CDMO to fleece shareholders again like she fleeced Woodford because they didn’t learn from their better the first time.
Didn’t you even read the link? It’s been discussed before. No it’s not DCVax. The female Dr is an experienced ground breaking oncologist with access to all information on treating GBM and didn’t choose DCVax. What’s that tell you?
That’s a lot of words to admit you are a hypocrite.
You would think someone who claims they know what the hell they are doing in this space could find a transcript from Merck.
Or just make something up, like you do with most your posts.
Ooooh now I'll make up some BS as to why Nike is interested in NWBO. And it will be as likely as your new loaf of bread.
Insiders at successful companies sell all the time. Try looking up a 10b5-1.
Crappy companies just dilute the hell out of their OS and do shady things like set up other companies, fund them on the backs of shareholders, then sell them and keep the profits for themselves. (See Cognate, and soon to be Advent).
You are obviously stock-picking challenged too.
15 years later you are still trying to convince people that every path, avenue and regulation designed to shorten the path to product approval MUST BE WHAT NWBO IS DOING and you've been wrong every single time. Even those that appear AFTER NWBO has submitted things. Like there's some wink wink nod nod between NWBO and any regulator. None of them knows who NWBO is and neither does BP. It's a failed penny stock hiding on the OTC.
You are simply wrong 100% of the time.
They would have made the decision to acquire this a long time ago if they liked what they saw. They didn't.
They didn't make the move after the interim data and they didn't make the move after TLD and seeing the large trainwreck the P3 has become.
The FDA has guidance for using an ECA. NWBO hasn't followed it.
You do understand that all that means is that Advent can be a CDMO for companies with actual products. NWBO is not one of them. So Advent benefits from this, not NWBO. Just like Cognate. Remember them?
Advent already uses the cold storage for other companies. I already linked to two of them. Where's that on the financial filings of NWBO? Nowhere, because they aren't making any money.
The hilarity of "charting" this POS when all you longs say it's not proper to sell. EVER.
The only thing to chart with this is a spreadsheet showing how the SP reacts to every NWBO PR. Just like any standard pump and dump. And that's exactly what I did. I played the pump and dump as easily as the friendly financiers.
And BTW, if spoofing is so prevalent it kinda defeats the purpose of charting anyway, doesn't it?
It made it there all on it's own based on the crap data and timeline which never ends and deadlines never met.
Finally a bit of volume. Probably the company dumping more shares. 2 billion OS right around the corner.
I don't know what you are babbling about. Let me know when you make a point.
Companies that need to "dilute like mad" are not ones who get $100 million from a friendly institutional investor AFTER the majority of patients in their lone trial of significance have already been enrolled.